ERTUGLIFLOZIN film-coated tablets (Steglatro®▼) as triple part of a therapy regimen for type 2 diabetes - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

ERTUGLIFLOZIN film-coated tablets (Steglatro®▼) as triple part of a therapy regimen for type 2 diabetes

Last Updated: 27 March 2019

Body System: Endocrine System

Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of ERTUGLIFLOZIN film-coated tablets (Steglatro®▼) for use as part of a triple therapy regimen for the treatment of type 2 diabetes.